| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (CL 9080 + methicillin-susceptible) |
- |
- |
4 － ? |
Azithromycin (Zithromax, Sumamed, Zitrocin)  |
1072 |
| Staphylococcus aureus (CL 9080 + methicillin-susceptible) |
- |
- |
4 － ? |
Viriditoxin |
1072 |
| Staphylococcus aureus (CL 9656 + tetracycline-resistant) |
- |
- |
0.25 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1072 |
| Staphylococcus aureus (CL 9656 + tetracycline-resistant) |
- |
- |
4 － ? |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
1072 |
| Staphylococcus aureus (CL 9656 + tetracycline-resistant) |
- |
- |
4 － ? |
Viriditoxin |
1072 |
| Staphylococcus aureus (CL 9656 + tetracycline-resistant) |
- |
- |
16 － ? |
Tetracycline (Sumycin, Achromycin V, Steclin) |
1072 |
| Staphylococcus aureus (CL 9689A + tetracycline-resistant + ciprofloxacin-resistant) |
- |
- |
4 － ? |
Viriditoxin |
1072 |
| Staphylococcus aureus (CL 9689A + tetracycline-resistant + ciprofloxacin-resistant) |
- |
- |
>16 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1072 |
| Staphylococcus aureus (CL 9689A + tetracycline-resistant + ciprofloxacin-resistant) |
- |
- |
>32 － ? |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
1072 |
| Staphylococcus aureus (CL 9689A + tetracycline-resistant + ciprofloxacin-resistant) |
- |
- |
32 － ? |
Tetracycline (Sumycin, Achromycin V, Steclin) |
1072 |
| Staphylococcus aureus (CL 9959 + methicillin-susceptible) |
- |
- |
0.12 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1072 |
| Staphylococcus aureus (CL 9959 + methicillin-susceptible) |
- |
- |
0.25 － ? |
Tetracycline (Sumycin, Achromycin V, Steclin) |
1072 |
| Staphylococcus aureus (CL 9959 + methicillin-susceptible) |
- |
- |
4 － ? |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
1072 |
| Staphylococcus aureus (CL 9959 + methicillin-susceptible) |
- |
- |
4 － ? |
Viriditoxin |
1072 |
| Staphylococcus aureus (clindamycin-resistant + erythromycin-resistant + methicillin-resistant) |
- |
- |
>128 － ? |
Clindamycin (Cleocin) |
1562 |
| Staphylococcus aureus (clinical isolate + methicillin-resistant) |
0.06 |
32 |
≤0.06 － >=128 |
Rifampicin (Rifampin) |
477 |
| Staphylococcus aureus (clinical isolate + methicillin-resistant) |
0.5 |
1 |
0.12 － 4 |
Quinupristin/Dalfopristin (Synercid) |
477 |
| Staphylococcus aureus (clinical isolate + methicillin-resistant) |
1 |
2 |
0.25 － >=128 |
Vancomycin (Vancocyn, Lyphocin) |
477 |
| Staphylococcus aureus (clinical isolate + methicillin-resistant) |
1 |
4 |
0.25 － >=128 |
Teicoplanin (Targocid) |
477 |
| Staphylococcus aureus (clinical isolate + methicillin-resistant) |
16 |
32 |
0.12 － >=128 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
477 |
| Staphylococcus aureus (clinical isolate + methicillin-susceptible) |
≤0.06 |
≤0.06 |
≤0.06 － 32 |
Rifampicin (Rifampin) |
477 |
| Staphylococcus aureus (clinical isolate + methicillin-susceptible) |
0.25 |
0.5 |
≤0.06 － 4 |
Quinupristin/Dalfopristin (Synercid) |
477 |
| Staphylococcus aureus (clinical isolate + methicillin-susceptible) |
0.5 |
1 |
≤0.06 － 32 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
477 |
| Staphylococcus aureus (clinical isolate + methicillin-susceptible) |
0.5 |
1 |
0.12 － 4 |
Teicoplanin (Targocid) |
477 |
| Staphylococcus aureus (clinical isolate + methicillin-susceptible) |
1 |
2 |
≤0.06 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
477 |
| Staphylococcus aureus (clinical isolate) |
- |
- |
3.125 － ? |
Rosemary (Essential oil) |
1075 |
| Staphylococcus aureus (clone 16 (grl(A)[S80P]) + CAMHB + pH 5.8) |
- |
- |
0.03 － ? |
Finafloxacin |
1045 |
| Staphylococcus aureus (clone 16 (grl(A)[S80P]) + CAMHB + pH 5.8) |
- |
- |
2 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1045 |